No Data
No Data
Buy Rating Affirmed for Atara Biotherapeutics on Strong Pipeline and Financial Health
Atara Biotherapeutics | 10-Q: Quarterly report
Express News | Atara Biotherapeutics Q1 2024 GAAP EPS $(0.23) Beats $(0.25) Estimate
Express News | Atara Biotherapeutics Inc - Cash Runway Into 2027 Enables Key Pipeline Readouts
Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M
04:04 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M
Express News | Atara Biotherapeutics Q1 Net Income USD -31.752 Million